Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] von Lakdawalla, Darius N., Doshi, Jalpa A., Garrison, Louis P., Phelps, Charles E., Basu, Anirban, Danzon, Patricia M.

Volltext

An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report [2] von Garrison, Louis P., Pauly, Mark V., Willke, Richard J., Neumann, Peter J.

Volltext

Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next? von Garrison, Jr, Louis P

Volltext

Incorporating Real Option Value in Valuing Innovation: A Way Forward von Li, Meng, Garrison, Louis P.

Volltext

Paying for Kidneys: Reflections on Welfare Economics, Political Economy, and Market Design von Garrison, Louis P.

Volltext

Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the “Age of Cures” and Their Implications for Dynamic Efficiency von Garrison, Louis P., Jiao, Boshen, Dabbous, Omar

Volltext

Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis von Garrison, Louis P., PhD, Kamal-Bahl, Sachin, PhD, Towse, Adrian, MA, MPhil

Volltext

A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1] von Neumann, Peter J., Willke, Richard J., Garrison, Louis P.

Volltext

Performance-Based Risk-Sharing Arrangements: An Updated International Review von Carlson, Josh J., Chen, Shuxian, Garrison, Louis P.

Volltext

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics von Garrison, Louis P, Towse, Adrian

Volltext

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019 von Garrison, Louis P., Jiao, Boshen, Elsisi, Zizi, Yehoshua, Alon, Koruth, Roy, Kreter, Bruce, Grueger, Jens

Volltext

Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report von Garrison, Louis P., PhD (cochair), Neumann, Peter J., ScD (cochair), Erickson, Pennifer, PhD, Marshall, Deborah, PhD, Mullins, C. Daniel, PhD

Volltext

Can’t Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products... von Towse, Adrian, Garrison, Louis P.

Volltext

Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies von Garrison, Louis P., Jiao, Boshen, Dabbous, Omar

Volltext

Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness Threshold von Garrison, Louis P., Jackson, Tristen, Paul, Douglas, Kenston, Mike

Volltext

Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrange... von Garrison, Louis P., PhD, Towse, Adrian, MA, MPhil, Briggs, Andrew, MSc, DPhil, de Pouvourville, Gerard, PhD, Grueger, Jens, PhD, Mohr, Penny E., MA, Severens, J.L. (Hans), PhD, Siviero, Paolo, BA, Sleeper, Miguel, ACMA

Volltext

Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview von Garrison, Louis P., PhD

Volltext

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework von Jiao, Boshen, Carlson, Josh J., Garrison, Louis P., Basu, Anirban

Volltext

Is the price right? Paying for value today to get more value tomorrow von Ramagopalan, Sreeram V, Diaz, Jose, Mitchell, Grace, Garrison, Jr, Louis P, Kolchinsky, Peter

Volltext

Is the world ready for gene therapy? von Garrison, Louis P., Kleinermans, Diane

Volltext